Neurofilament inclusion body disease: a new proteinopathy?

We describe four cases of a new clinicopathological entity presenting with either a frontotemporal dementia or corticobasal degeneration syndrome with a mean age of onset of 45 years (range 41-50) characterized pathologically by deposition of neurofilament proteins. All four patients had a rapidly progressive course and have become mute and non-ambulatory, and three have died after mean illness duration of only 3 years (range 2 1/2 -4). Both structural (MRI) and functional (PET and SPECT) imaging demonstrated frontal and temporal lobe and basal ganglia involvement. Gross neuropathological examination in the three deceased patients (the fourth patient, still alive, was diagnosed by brain biopsy) revealed changes affecting predominantly the frontal and temporal cortices, basal ganglia and brainstem. There was superficial linear spongiosis affecting the frontal lobes in all three autopsied patients, and severe caudate atrophy was noted in two of them and demonstrated on MRI in the living patient. On routine staining, there were numerous intracytoplasmic inclusions, which ranged from eosinophilic to basophilic. Some had a clearly defined basophilic margin, while others were granular with a hyaline core. With modified Bielschowsky silver technique, a small number of the inclusions were intensely stained. Inclusions were not labelled with other silver stains. Immuno histochemistry revealed that the inclusions were immunoreactive with antibodies to neurofilament heavy and light chain subunits and to ubiquitin, but not with antibodies to tau and alpha-synuclein. These neurofilament- and ubiquitin-positive inclusions were widespread, specific to neurons and occasionally intranuclear. The frequency and distribution of the inclusions and the silver and immunohistochemical profiles in these four cases is novel and has not been described in detail before. We propose the term neurofilament inclusion body disease for this entity.

[1]  Yoichi Nakazato,et al.  New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis , 1991, Neuroscience Letters.

[2]  Julie S Snowden,et al.  Frontotemporal dementia , 2002, British Journal of Psychiatry.

[3]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[4]  B Miller,et al.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. , 2001, Archives of neurology.

[5]  Andrew Kertesz,et al.  Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions , 2001, Acta Neuropathologica.

[6]  D Danieli,et al.  Panencephalopathic type of Creutzfeldt-Jakob disease with neuropathologic features similar to Pick's disease. , 1993, Clinical neuropathology.

[7]  I Litvan,et al.  Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination , 1998, Journal of neurology, neurosurgery, and psychiatry.

[8]  Yasuko Hayashi,et al.  Hereditary dentatorubral-pallidoluysian atrophy: detection of widespread ubiquitinated neuronal and glial intranuclear inclusions in the brain , 1998, Acta Neuropathologica.

[9]  R. Hauser,et al.  Magnetic Resonance Imaging of Corticobasal Degeneration , 1996, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[10]  D. Neary,et al.  Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia , 1992, Neuroscience Letters.

[11]  R. Petersen,et al.  Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia , 1999, Neurology.

[12]  S. Ludwin,et al.  Classic and generalized variants of Pick's disease: A clinicopathological, ultrastructural, and immunocytochemical comparative study , 1984, Annals of neurology.

[13]  E. Faccio,et al.  5-08-14 Subcortical akinetic mutism: Report of three cases , 1997, Journal of Neurological Sciences.

[14]  M N Rossor,et al.  Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. , 2000, Brain : a journal of neurology.

[15]  D. Knopman,et al.  Dementia lacking distinctive histologie features , 1990, Neurology.

[16]  J. Lowe,et al.  Motor neurone disease-inclusion dementia. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[17]  D. Mann,et al.  Dementia of Frontal Type and Dementias with Subcortical Gliosis , 1998, Brain pathology.

[18]  Fumiaki Tanaka,et al.  Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy , 1998, Annals of neurology.

[19]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.

[20]  Nigel J. Cairns,et al.  Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.

[21]  R A Crowther,et al.  Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. , 1998, Neuroscience letters.

[22]  S. Ludwin,et al.  Adult‐onset neuronal intra nuclear hyaline inclusion disease , 1986, Neurology.

[23]  Yoichi Nakazato,et al.  A case of Pick's disease with unusual neuronal inclusions , 2004, Acta Neuropathologica.

[24]  Takeshi Nishio,et al.  Immunohistochemical and ultrastructural characterization of ubiquitinated eosinophilic fibrillary neuronal inclusions in sporadic amyotrophic lateral sclerosis , 1998, Acta Neuropathologica.

[25]  J. Trojanowski,et al.  Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells , 2004, Acta Neuropathologica.

[26]  K. Oyanagi,et al.  Distribution of basal ganglia lesions in generalized variant of Pick's disease: a clinicopathological study of four autopsy cases , 2001, Acta Neuropathologica.

[27]  J. Bogousslavsky,et al.  Anterior cerebral artery territory infarction in the Lausanne Stroke Registry. Clinical and etiologic patterns. , 1990, Archives of neurology.

[28]  R A Crowther,et al.  From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[29]  Jean-Pierre Julien,et al.  Neurofilament functions in health and disease , 1999, Current Opinion in Neurobiology.

[30]  J. Trojanowski,et al.  Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.

[31]  Ian G. McKeith,et al.  Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions , 2003, Neuroscience Letters.

[32]  Mrc Psych,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop , 1996 .

[33]  T D Bird,et al.  Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions , 2000, Neurology.

[34]  J. Holton,et al.  Evidence for pathological involvement of the spinal cord in motor neuron disease-inclusion dementia , 2002, Acta Neuropathologica.

[35]  R. Nixon,et al.  The Regulation of Neurofilament Protein Dynamics by Phosphorylation: Clues to Neurofibrillary Pathobiology , 1993, Brain pathology.

[36]  Elna-Marie Larsson,et al.  Magnetic Resonance Imaging and Histopathology in Dementia, Clinically of Frontotemporal Type , 2000, Dementia and Geriatric Cognitive Disorders.

[37]  H. Budka,et al.  Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease , 2000, Neurology.

[38]  A Dürr,et al.  Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. , 1998, Human molecular genetics.

[39]  E. Faccio,et al.  Akinetic mutism: a report of three cases , 1998, Acta neurologica Scandinavica.

[40]  I. Zerr,et al.  Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease. , 2000, Archives of neurology.

[41]  M. Freedman,et al.  Frontotemporal lobar degeneration , 1998, Neurology.

[42]  Mark Turmaine,et al.  Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.

[43]  John Q Trojanowski,et al.  Polyglutamine-containing aggregates in neuronal intranuclear inclusion disease , 1998, The Lancet.

[44]  James Lowe,et al.  Establishing a Pathological Diagnosis in Degenerative Dementias , 1998, Brain pathology.

[45]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[46]  A. Kertesz,et al.  Pick's disease and Pick complex , 1998 .

[47]  J Q Trojanowski,et al.  Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. , 1998, The American journal of pathology.

[48]  Lillian Martinian,et al.  Neuronal intranuclear inclusions in SCA2: a genetic, morphological and immunohistochemical study of two cases. , 2002, Brain : a journal of neurology.

[49]  Saburo Sakoda,et al.  [Presenile dementia with motor neuron disease]. , 2004, Nihon rinsho. Japanese journal of clinical medicine.

[50]  D W Dickson,et al.  Intranuclear inclusion bodies in an elderly demented woman: a form of intranuclear inclusion body disease. , 1995, Clinical neuropathology.

[51]  T. Uchihara,et al.  Neuronal intranuclear hyaline inclusion disease with polyglutamine-immunoreactive inclusions , 2000, Acta Neuropathologica.

[52]  Alexander Varshavsky,et al.  The ubiquitin system. , 1998, Annual review of biochemistry.